Once-weekly versus every-other-day stereotactic body radiotherapy in patients with prostate cancer (PATRIOT): A phase 2 randomised trial

Prostate stereotactic body radiotherapy regimens differ in time, dose, and fractionation. This study is a multi-centre, randomised phase II study to investigate the impact of overall treatment time on quality of life.
UroToday